We provide rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. We are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialisation of pharmaceutical products. Our current portfolio of antidotes counteract certain snake venoms and the toxicity associated with some heart and cancer medications.
Copperhead: The Jacob Rodney Cohen of Snakes
Why are copperhead envenomations so often minimized
by both laypeople and healthcare professionals?
Could humans...produce venom?
A study of genes has people considering what, on the face of it, seems like something out of a bad sci-fi movie.
Does digoxin deserve a second look? New study adds data to the conversation
Prof. Dipak Kotecha describes the journey leading to the publication of the RATE-AF trial